Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Mind Gym (MIND) by Steve Moore in ShareProphets
- Avoid Made Tech Group (MTEC) by Steve Moore in ShareProphets
- Sell Technology Minerals (TM1) by Tom Winnifrith in ShareProphets
- Add Legal & General Group (LGEN) by Charlie Keough in The Motley Fool
- Avoid Aferian (AFRN) by Steve Moore in ShareProphets
- Sell Petrofac Ltd. (PFC) by Lucian Miers in ShareProphets
- Underperform Sainsbury (J) (SBRY) by Bank of America
- Add HSBC Holdings (HSBA) by Charlie Keough in The Motley Fool
- Hold Rolls-Royce Holdings (RR.) by Mark David Hartley in The Motley Fool
- Buy National Grid (NG.) by UBS
- Neutral London Stock Exchange Group (LSEG) by UBS
- Neutral South32 Limited (DI) (S32) by Citi
- Neutral Associated British Foods (ABF) by UBS
- Buy Tinybuild Inc. (DI) (TBLD) by Berenberg
- Hold Learning Technologies Group (LTG) by Berenberg
- Outperform Watches of Switzerland Group (WOSG) by RBC Capital
- Neutral Rentokil Initial (RTO) by JP Morgan
- Neutral easyJet (EZJ) by Goldman Sachs
- Hold Reckitt Benckiser Group (RKT) by Jefferies
- Buy Watches of Switzerland Group (WOSG) by Jefferies
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,302 open tips for GSK (GSK)
| Latest Bid : 1,649.50p | Latest Ask : 1,650.50p |
| High Today : 1,656.00p | Low Today : 1,636.50p |
| This Years High : 1,711.20p | This Years Low : 1,316.00p |
| Volume : 1,839,928 | MKT Cap : £68396.72M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Equal Weight | Barclays | Premium Only | 2023-09-04 17:45:00 04/09/2023 | 6.79% |
| Buy | Edward Sheldon | Premium Only | 2023-08-28 07:30:00 28/08/2023 | 18.72% |
| Buy | LBBW | Premium Only | 2023-08-07 12:52:00 07/08/2023 | 18.68% |
| Underweight | JP Morgan | Premium Only | 2023-07-31 06:22:00 31/07/2023 | -19.43% |
| Buy | Berenberg | Premium Only | 2023-07-28 18:00:00 28/07/2023 | 19.36% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,649.50p | Latest Ask : 1,650.50p |
| High Today : 1,656.00p | Low Today : 1,636.50p |
| This Years High : 1,711.20p | This Years Low : 1,316.00p |
| Volume : 1,839,928 | MKT Cap : £68396.72M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Equal Weight | Barclays | Premium Only | 2023-09-04 17:45:00 04/09/2023 | 6.79% |
| Buy | Edward Sheldon | Premium Only | 2023-08-28 07:30:00 28/08/2023 | 18.72% |
| Buy | LBBW | Premium Only | 2023-08-07 12:52:00 07/08/2023 | 18.68% |
| Underweight | JP Morgan | Premium Only | 2023-07-31 06:22:00 31/07/2023 | -19.43% |
| Buy | Berenberg | Premium Only | 2023-07-28 18:00:00 28/07/2023 | 19.36% |